ImmunoProfile provides an at-home diagnostic testing system that evaluates an individual's antibody levels for eleven common, vaccine-preventable infectious diseases using a finger-prick blood sample. The company serves families, healthcare workers, students, travelers, and employers seeking to assess immunity status and identify potential gaps in protection.
Subscribe to see IMMUNOPROFILE, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
IMMUNOPROFILE, LLC is a healthcare & biotechnology company headquartered in Marco Island, United States. Its most recent funding round raised $230,000 in October 2025. Xcout tracks 2 named people at IMMUNOPROFILE, LLC, including Sudip Ghatak (Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $230,000 | — | |
| SEC Form D filing | $150,000 | — | |
| SEC Form D filing | $600,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of IMMUNOPROFILE, LLC's closest competitors — see the full list of competitors and alternatives →
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Immy Inc. develops, manufactures, and distributes diagnostic tests, reagents, and processing systems specializing in mycology. The company serves healthcare professionals, reference laboratories, and hospital settings by providing lateral flow assays, enzyme immunoassays, and PCR tests for the detection of fungal diseases.
Galaxy Diagnostics was founded to solve the challenge of diagnosing stealth pathogens that often go undetected by traditional medical tests. The company provides specialized testing information, kits, and support to patients and healthcare providers.
Immunaeon provides cellular preservation and long-term cryogenic storage services for individuals, families, and patients seeking to bank healthy immune cells for future use. The company guides clients through a consultation, collection, processing, and storage process, offering informational health analyses without providing direct medical treatment or diagnosis.
Incite Health Life Sciences, Inc. is a CLIA-certified and CAP-accredited high-complexity clinical laboratory that provides specialized diagnostic testing, including pharmacogenomics, infectious disease screening, and immune system monitoring. The company serves physicians, medical institutions, employers, and clinical trials by utilizing advanced methodologies and data-driven approaches to support early detection, disease monitoring, and personalized medicine.
Nanopath is a biotechnology and diagnostics company developing rapid molecular testing systems, with an emphasis on decentralized point-of-care testing. Its products are intended for healthcare providers and clinical laboratories, including applications in women’s health and infectious-disease diagnosis.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about IMMUNOPROFILE, LLC? Suggest a correction · Work at IMMUNOPROFILE, LLC? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.